These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 12856774)

  • 1. Population pharmacokinetics of marbofloxacin in aqueous humor after intravenous administration in dogs.
    Regnier A; Concordet D; Schneider M; Boisramé B; Toutain PL
    Am J Vet Res; 2003 Jul; 64(7):889-93. PubMed ID: 12856774
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intraocular pharmacokinetics of intravenously administered marbofloxacin in rabbits with experimentally induced acute endophthalmitis.
    Regnier A; Schneider M; Concordet D; Toutain PL
    Am J Vet Res; 2008 Mar; 69(3):410-5. PubMed ID: 18312141
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacokinetic characteristics and tissue residues for marbofloxacin and its metabolite N-desmethyl-marbofloxacin in broiler chickens.
    Anadón A; Martínez-Larrañaga MR; Díaz MJ; Martínez MA; Frejo MT; Martínez M; Tafur M; Castellano VJ
    Am J Vet Res; 2002 Jul; 63(7):927-33. PubMed ID: 12118670
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacokinetics of marbofloxacin in mature horses after single intravenous and intramuscular administration.
    Carretero M; Rodríguez C; San Andrés MI; Forés P; de Lucas JJ; Nieto J; Waxman S; San Andrés MD; González F
    Equine Vet J; 2002 Jul; 34(4):360-5. PubMed ID: 12117107
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Pharmacokinetics of balofloxacin in the intraocular tissues of pigmented rabbits].
    Ooishi M; Miyao M; Abe T; Sasagawa T; Motoyama M; Nakagawa T; Okutomi T
    Jpn J Antibiot; 1995 Sep; 48(9):1274-80. PubMed ID: 7474337
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacokinetics of marbofloxacin in dogs after oral and parenteral administration.
    Schneider M; Thomas V; Boisrame B; Deleforge J
    J Vet Pharmacol Ther; 1996 Feb; 19(1):56-61. PubMed ID: 8992027
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacokinetics of marbofloxacin in horses.
    Bousquet-Melou A; Bernard S; Schneider M; Toutain PL
    Equine Vet J; 2002 Jul; 34(4):366-72. PubMed ID: 12117108
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacokinetics of marbofloxacin in blue and gold macaws (Ara ararauna).
    Carpenter JW; Hunter RP; Olsen JH; Henry H; Isaza R; Koch DE
    Am J Vet Res; 2006 Jun; 67(6):947-50. PubMed ID: 16740085
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacokinetics and pharmacokinetic/pharmacodynamic integration of marbofloxacin in calf serum, exudate and transudate.
    Aliabadi FS; Lees P
    J Vet Pharmacol Ther; 2002 Jun; 25(3):161-74. PubMed ID: 12081611
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Aqueous humor levels of topically applied levofloxacin, norfloxacin, and lomefloxacin in the same human eyes.
    Yamada M; Mochizuki H; Yamada K; Kawai M; Mashima Y
    J Cataract Refract Surg; 2003 Sep; 29(9):1771-5. PubMed ID: 14522299
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of experimental renal impairment on disposition of marbofloxacin and its metabolites in the dog.
    Lefebvre HP; Schneider M; Dupouy V; Laroute V; Costes G; Delesalle L; Toutain PL
    J Vet Pharmacol Ther; 1998 Dec; 21(6):453-61. PubMed ID: 9885968
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparative serum pharmacokinetics of the fluoroquinolones enrofloxacin, difloxacin, marbofloxacin, and orbifloxacin in dogs after single oral administration.
    Heinen E
    J Vet Pharmacol Ther; 2002 Feb; 25(1):1-5. PubMed ID: 11874520
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prevention of surgical infections in dogs with a single intravenous injection of marbofloxacin: an experimental model.
    Gruet P; Richard P; Thomas E; Autefage A
    Vet Rec; 1997 Feb; 140(8):199-202. PubMed ID: 9061872
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The ocular penetration of oral sparfloxacin in humans.
    Bron AM; Pechinot AP; Garcher CP; Guyonnet GA; Kazmierczak AM; Schott DA; Lecoeur H
    Am J Ophthalmol; 1994 Mar; 117(3):322-7. PubMed ID: 8129004
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacokinetics of marbofloxacin in renal impairment in the dog.
    Lefebvre HP; Dupouy V; Schneider M; Laroute V; Toutain PL
    Vet Q; 1998; 20 Suppl 1():S104. PubMed ID: 9652038
    [No Abstract]   [Full Text] [Related]  

  • 16. Integration of pharmacokinetic and pharmacodynamic indices of marbofloxacin in turkeys.
    Haritova AM; Rusenova NV; Parvanov PR; Lashev LD; Fink-Gremmels J
    Antimicrob Agents Chemother; 2006 Nov; 50(11):3779-85. PubMed ID: 16940071
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The disposition of marbofloxacin in Eurasian buzzards (Buteo buteo) after intravenous administration.
    Garcia-Montijano M; Waxman S; Sánchez C; Quetglas J; San Andrés MI; González F; Rodríguez C
    J Vet Pharmacol Ther; 2001 Apr; 24(2):155-7. PubMed ID: 11442792
    [No Abstract]   [Full Text] [Related]  

  • 18. Penetration of gatifloxacin eye drops into the aqueous humor in humans.
    Teshigawara T; Hata S; Hayashi T; Watanabe Y; Itoh Y; Hitoi K; Mizuki N
    Ocul Immunol Inflamm; 2007; 15(4):309-13. PubMed ID: 17763128
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of the concentration of marbofloxacin in alveolar macrophages and pulmonary epithelial lining fluid after administration in dogs.
    Boothe HW; Jones SA; Wilkie WS; Boeckh A; Stenstrom KK; Boothe DM
    Am J Vet Res; 2005 Oct; 66(10):1770-4. PubMed ID: 16273909
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of the clinical efficacy of marbofloxacin (Zeniquin) tablets for the treatment of canine pyoderma: an open clinical trial.
    Paradis M; Abbey L; Baker B; Coyne M; Hannigan M; Joffe D; Pukay B; Trettien A; Waisglass S; Wellington J
    Vet Dermatol; 2001 Jun; 12(3):163-9. PubMed ID: 11420932
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.